[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Pro].

Wolfgang  Brückl

doi:10.1055/s-0031-1298873

[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Pro].

Wolfgang Brückl^* (First author)

^*Corresponding author for this work

Department of Internal Medicine III, Division of Respiratory Medicine, Allergology and Sleep Medicine

Research output: Contribution to journal › Editorial › peer-review

Original language	German
Pages (from-to)	592
Journal	DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT
Volume	137
Issue number	12
DOIs	https://doi.org/10.1055/s-0031-1298873
Publication status	Published - 2012

Keywords

GEFITINIB
1ST-LINE
CANCER

Access to Document

10.1055/s-0031-1298873

Cite this

@article{9b227567ce9f4c6e831fe2ebb52fb4c1,

title = "[Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Pro].",

keywords = "GEFITINIB, 1ST-LINE, CANCER",

author = "Wolfgang Br{\"u}ckl",

note = "Prof. Dr. med. Wolfgang Br{\"u}ckl, Leiter der pneumologischen Onkologie, Medizinische Klinik 3, Lungentumorzentrum N{\"u}rnberg, Prof.-Ernst-Nathan-Str. 1, 90419 N{\"u}rnberg",

year = "2012",

doi = "10.1055/s-0031-1298873",

language = "Deutsch",

volume = "137",

pages = "592",

journal = "DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT",

issn = "0012-0472",

number = "12",

}

TY - JOUR

T1 - [Should we always use EGFR mutation analysis prior to palliative firstline therapy of metastatic adenocarcinoma of the lung? Pro].

AU - Brückl, Wolfgang

N1 - Prof. Dr. med. Wolfgang Brückl, Leiter der pneumologischen Onkologie, Medizinische Klinik 3, Lungentumorzentrum Nürnberg, Prof.-Ernst-Nathan-Str. 1, 90419 Nürnberg

PY - 2012

Y1 - 2012

KW - GEFITINIB

KW - 1ST-LINE

KW - CANCER

U2 - 10.1055/s-0031-1298873

DO - 10.1055/s-0031-1298873

M3 - Editorial

C2 - 22415622

SN - 0012-0472

VL - 137

SP - 592

JO - DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

JF - DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT

IS - 12

ER -